longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

China BlueChemical Schedules Board Meeting to Approve Interim Results

Tip Ranks
Aug 4, 2026 at 09:12 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

China BlueChemical (HK:3983) announced that its board of directors will convene on August 18-19, 2026, to review corporate performance and approve the interim results for the six months ended June 30, 2026. This meeting signals the forthcoming release of half-year financial figures, which are expected to shape investor expectations regarding the company's operational and financial trajectory.

China BlueChemical ( (HK:3983) ) has issued an update.

China BlueChemical Ltd., a PRC-incorporated joint stock company listed in Hong Kong under stock code 3983, has announced that its board of directors will convene in mid-August to review corporate performance. The company’s governance framework includes a mix of executive, non-executive and independent non-executive directors, reflecting its adherence to Hong Kong corporate governance standards.

The board meeting will be held from 18 to 19 August 2026 to consider and approve the interim results for the six months ended 30 June 2026 for publication. The scheduled review signals the forthcoming release of half-year financial figures, an event likely to shape investor expectations and provide fresh insight into the company’s operational and financial trajectory for the rest of the year.

More about China BlueChemical

China BlueChemical Ltd. is a joint stock limited company incorporated in the People’s Republic of China and listed in Hong Kong under stock code 3983. The company operates in the chemical sector and oversees a group of subsidiaries, with a board comprising executive, non-executive and independent non-executive directors based in Beijing, reflecting its governance and market presence.

The board structure, including executive directors Hou Xiaofeng and Rao Shicai, non-executive directors Shao Lihua and He Qizhong, and independent non-executive directors Lin Feng, Xie Dong and Yang Wanhong, underpins the company’s compliance with Hong Kong listing rules and corporate governance norms.

Average Trading Volume: 5,863,483

Technical Sentiment Signal: Buy

Current Market Cap: HK$9.77B

Learn more about 3983 stock on TipRanks’ Stock Analysis page.

Login to unlock1,225characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

China BlueChemical

China BlueChemical

USCBLUY

0.00%

CHINA BLUECHEM

CHINA BLUECHEM

HK03983

-1.99%

LongbridgeAI